PROMIS® scores in operative metastatic bone disease patients: A multicenter, prospective study.

Alan T BlankDaniel M LermanSara ShawFarnaz DadrassYue ZhangWei LiuMan HungKevin B JonesR Lor Randall

Published in: Journal of surgical oncology (2018)

PROMIS® provides a feasible means to collect data in this population. Trends of improved function and decreased pain were seen after surgery. Continuing this study will hopefully elucidate more insight into the surgical treatment of MBD.

Keyphrases

patient reported outcomes
end stage renal disease
ejection fraction
newly diagnosed
squamous cell carcinoma
chronic kidney disease
chronic pain
small cell lung cancer
prognostic factors
pain management
neuropathic pain
clinical trial
machine learning
postmenopausal women
medical education
bone regeneration